gaintherapeutics.com (GANX): Growth-Adjusted P/E Ratio

Symbol and logo of brand gaintherapeutics.com (GANX)

Gain Therapeutics, Inc. (GANX) is a digital innovator utilizing the SEE-Tx supercomputing system to combat rare pathologies. The upward trend in the P/E ratio demonstrates market expectations, while the 0.00 mark reflects the latest data. Gain Therapeutics, Inc. (GANX) focuses on the clinical advancement of its Parkinson's disease drug and B2B partnerships. Its operations are based on Swiss-American research into protein structures for the therapy of neurodegeneration.

GANX - Gain Therapeutics, Inc. PEG Multiple over the range 07/04/2022 - 11/16/2026

Analytical breakdowns for Gain Therapeutics Inc. (GANX)

- current quotes and average value forecast:
Fundamental company analysis:Gain Therapeutics, Inc. (GANX)
Signature product of Gain Therapeutics

Investors are seeking objective fundamental benchmarks to assess the potential of Gain Therapeutics, Inc. (GANX). The PEG ratio compares the current market multiple to earnings growth rates, where a value below one signals that the asset is undervalued. The PEG ratio trajectory on the GURU.Markets platform allows for the verification of this pattern. The efficiency of the company's computing platform in optimizing drug development directly impacts the dynamics of this coefficient. The business's high margins make this metric a key filter for identifying growth opportunities.

Who Gain Therapeutics, Inc. competes with

HCA Holdings - Growth-Adjusted P/E Ratio|Tenet - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio FMS (Fresenius Medical Care)|SOLV: Price/Earnings to Growth Multiple|Price to Earnings Adjusted for Growth Rate Encompass Health Corp|Universal Health Services (UHS) - Price/Earnings to Growth Ratio|DaVita Inc. (DVA) - PEG Multiple|RDNT (RadNet Management) - PEG Multiple|Option Care Health, Inc. - Market Cap to Earnings and Growth Ratio|Price/Earnings to Growth Ratio Surgery Partners (SGRY)|PINC - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio nationalvision.com EYE|Price to Net Income Growth Ratio Progyny, Inc.|ARDT - Price/Earnings to Growth Ratio|Select Medical Holdings - Company Value to Earnings Growth Ratio|Apollo Medical Holdings (ASTH) - Price/Earnings to Growth Ratio|MD - Growth-Adjusted Market Cap to Net Income|USPH (usph.com) - PEG Multiple|Growth-Adjusted P/E Ratio PNTG (The Pennant Group Corp)|PEG Multiple ORGO|NUTX - Price to Earnings Adjusted for Growth Rate|aunainvestors.com - Price/Earnings to Growth Multiple|PEG Multiple SBC Medical Group Holdings Inc. SBC|Evolus Corp - PEG Multiple|Growth-Adjusted Payback Ratio CYH (Community Health Systems Inc)|SKIN (Beauty Health) - Price/Earnings to Growth Multiple|MDWD (MediWound Ltd.) - Price/Earnings to Growth Ratio|BTMD (biote Corp) - PEG Multiple|Price to Earnings Adjusted for Growth Rate The Joint Corp JYNT|PEG Multiple DCGO|Price/Earnings to Growth Multiple p3hp.org PIII|PEG Multiple EUDA (EUDA Health)|Growth-Adjusted Payback Ratio BMGL|CollPlant Ltd - PEG Multiple|Price to Net Income Growth Ratio Cuprina Holdings (Cayman) Ltd. (CUPR)|Concord Medical Corp (CCM) - Price/Earnings to Growth Ratio|ASHS - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio MEDIROM Healthcare Group|PEG Multiple avalon-globocare.com|PEG Multiple DHAI|XAGE (Carmell Therapeutics Corporation) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio NewGenIvf Corp NIVF|ATIP (atipt.com) - Market Cap to Earnings and Growth Ratio|CareMax, Inc - PEG Multiple|Growth-Adjusted Payback Ratio KDLY (Kindly MD, Inc.)|MODV: PEG Multiple|Growth-Adjusted P/E Ratio NVOS|Price/Earnings to Growth Ratio SunLink Health Systems, Inc.|PEG Multiple IMAC Holdings, Inc.